Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Stemcyte, Inc.

Clinical trials sponsored by Stemcyte, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Cord blood infusion trial aims to beat long COVID fatigue Results expected Jun 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1 Not yet recruiting 1
Sort by
  • Cord blood infusion trial aims to beat long COVID fatigue

    Symptom relief Not yet recruiting

    This phase 3 trial tests whether a single infusion of human umbilical cord blood, called REGENECYTE, can reduce fatigue in people with Long COVID. Sixty adults with post-COVID condition will receive either the cord blood or a placebo (salt water) and be monitored for changes in f…

    Phase 3 • Sponsor: StemCyte, Inc. • Aim: Symptom relief

    Last updated Jun 27, 2026 07:51 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space